Ocular Therapeutix OCUL Derivative Gain Loss On Derivative And Other Net
Derivative Gain Loss On Derivative And Other Net at other companies
Other financials
Where this comes from
Reported directly by Ocular Therapeutix in its filing.
Tagged under the XBRL concept ocul:DerivativeGainLossOnDerivativeAndOtherNet.
The official record: Ocular Therapeutix’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ocular Therapeutix's derivative gain loss on derivative and other net.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ocular Therapeutix's derivative gain loss on derivative and other net?
- Ocular Therapeutix (OCUL) reported derivative gain loss on derivative and other net of $1.46M in Q1 2026.
- How has Ocular Therapeutix's derivative gain loss on derivative and other net changed year-over-year?
- Ocular Therapeutix's derivative gain loss on derivative and other net increased by 248.8% year-over-year, from -$978K to $1.46M.
- What does derivative gain loss on derivative and other net mean?
- This metric captures the net impact of gains or losses arising from derivative financial instruments held by the company. It reflects the volatility and valuation changes of these instruments, which are often used for hedging or strategic financial management purposes. Investors analyze this line item to understand how non-core financial activities and market fluctuations in derivative valuations influence the company's bottom-line net income.